Cognitive deficits in preclinical Alzheimer's disease

Acta Neurologica Scandinavica, Supplement

Volumn 107, Issue 179, 2003, Pages 29-33

  Small, Brent J ^a   Mobly, Jennifer L ^a   Laukka, Erika Jonsson ^b,c   Jones, Sari ^b,c   Bäckman, Lars ^b,c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UPPSALA UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Alzheimer's disease; Cognition; Episodic memory; Preclinical

Indexed keywords

AGING; ALZHEIMER DISEASE; BEHAVIOR DISORDER; COGNITION; COGNITIVE DEFECT; DISEASE ACTIVITY; DISEASE COURSE; ENTORHINAL CORTEX; HIPPOCAMPUS; HUMAN; MEMORY; REVIEW; RISK FACTOR; FOLLOW UP; MEMORY DISORDER; MINI MENTAL STATE EXAMINATION; FRONTAL LOBE; NEUROPSYCHOLOGICAL TEST; PATHOLOGY;

AGING; ALZHEIMER DISEASE; COGNITION DISORDERS; DISEASE PROGRESSION; ENTORHINAL CORTEX; FRONTAL LOBE; HIPPOCAMPUS; HUMANS; NEUROPSYCHOLOGICAL TESTS;

EID: 0037238306     PISSN: 00651427     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. SCHENK D, BARBOUR R, DUNN W et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 1999;400:173-7.
2. JACOBS DM, SANO M, DOONEIF G, MARDER K, BELL KL, STERN Y. Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology 1995;45:317-24.
3. ELIAS MF, BEISERIES A, WOLF PA, AU R, WHITE RF, D'AGOSTINO RB. The preclinical phase of Alzheimer's disease: a 22-year prospective study of the Framingham cohort. Arch Neurol 2000;57:808-13.
4. SMALL BJ, VIITANEN M, BÄCKMAN L. Mini-Mental State Examination item scores as predictors of Alzheimer's disease: Incidence data from the Kungsholmen project, Stockholm. J Geront Med Sci 1997;52:299-304.
5. TIERNEY MC, SZALAI JP, SNOW WG et al. Prediction of probable Alzheimer's disease in memory-impaired patients: a prospective longitudinal study. Neurology 1995;46:661-5.
6. JOHANSSON B, ZARIT SH. Early cognitive markers of the incidence of dementia and mortality: a longitudinal population-based study of the oldest old. Int J Geriatr Psychiatr 1997;12:53-9.
7. ARONSON MK, OOI WL, MORGENSTERN H et al. Women, myocardial infarction, and dementia in the very old. Neurology 1990;40:1102-6.
8. YOSHITAKE T, KIYOHARA Y, KATO I et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama study. Neurology 1995;45:1161-8.
9. MASUR DM, SLIWINSKI M, LIPTON RB, BLAU AD, CRYSTAL HA. Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology 1995;44:1427-32.
10. FABRIGOULE C, ROUCH I, TABERLY A et al. Cognitive processes in preclinical phase of dementia. Brain 1998;121:135-41.
11. LINN RT, WOLF PA, BACHMAN DL et al. The 'preclinical phase' of probable Alzheimer's disease. Arch Neurol 1995;52:485-90.
12. FABRIGOULE C, LAFONT S, LETENNEUR L et al. WAIS similarities subtest performances as predictors of dementia in elderly community residents. Brain Cognit 1996;30:323-6.
13. HOWIESON DB, DAME A, CAMICIOLI R, SEXTON G, PAYAMI H, KAYE JA. Cognitive markers preceding Alzheimer's dementia in the healthy oldest old. J Am Geriatr Soc 1997;45:584-9.
14. SMALL BJ, HERLITZ A, FRATIGLIONI L, ALMKVIST O, BÄCKMAN L. Cognitive predictors of incident Alzheimer's disease: a prospective longitudinal study. Neuropsychology 1997;11:413-20.
15. GROBER E, LIPTON RB, HALL C, CRYSTAL H. Memory impairment on free and cued selective reminding predicts dementia. Neurology 2000;54:827-32.
16. BÄCKMAN L, SMALL BJ. Influences of cognitive support on episodic remembering: Tracing the process of loss from normal aging to Alzheimer's disease. Psychol Aging 1998;13:267-76.
17. FULD PA, MASUR DM, BLAU AD, CRYSTAL HA, ARONSON MK. Object-memory evaluation for prospective detection of dementia in normal functioning elderly. J Clin Exp Neuropsychol 1990;12:520-8.
18. BÄCKMAN L, SMALL BJ, FRATIGLIONI L. Stability of the preclinical episodic memory deficit in Alzheimer's disease. Brain 2001;124:96-102.
19. SMALL BJ, FRATIGLIONI L. VIITANEN M, WINBLAD B, BÄCKMAN L. The course of cognitive impairment in preclinical Alzheimer's disease: 3- and 6-year follow-up of a population-based sample. Arch Neurol 2000;57:839-44.
20. LA RUE A, JARVIK LF. Cognitive function and prediction of dementia in old age. Int J Aging Hum Dev 1987;25:75-89.
21. SNOWDON DA, KEMPER SJ, MORTIMER JA, GREINER LH, WEKSTEIN DR, MARKESBERY WR. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. JAMA 1996;275:528-32.
22. WHALLEY LJ, STARR JM, ATHAWES R, HUNTER D, PATTIE A, DEARY IJ. Childhood mental ability and dementia. Neurology 2000;55:1455-9.
23. FOX NC, WARRINGTON EK, FREEBOROUGH PA et al. Presymptomatic hippocampal atrophy in Alzheimer's disease. Brain 1996;119:2001-7.
24. GOLDMAN WP, PRICE JL, STORANDT M et al. Absence of cognitive impairment or decline in preclinical Alzheimer's disease. Neurology 2001;56:361-7.
25. CHEW P, RATCLIFF G, BELLE SH, CAULEY JA, DEKOSKY ST, GANGULI M. Patterns of decline in pre-symptomatic Alzheimer's Disease: a prospective community study. Arch Gen Psychiatr 2001;58:853-8.
26. FOX NC, CRUM WR, SCAHILL RI, STEVENS JM, JANSSEN JC, ROSSOR MN. Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance imaging. Lancet 2001;358:201-5.
27. KILLIANY RJ, GOMEZ-ISLA T, MOSS M et al. Imaging to predict who will get Alzheimer's disease. Ann Neurol 2000;47:430-9.
28. SILVERMAN DHS, SMALL GW, CHANG CY et al. Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA 2001;286:2120-7.
29. DE LEON MJ, GEORGE AE, GOLOMB J et al. Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease. Neurobiol Aging 1997;18:1-11.
30. XU Y, JACK CR Jr, O'BRIEN PC et al. Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology 2000;54:1760-7.
31. JACK CR Jr, PETERSEN RC, XU YC et al. Prediction of AD with MRI-based hippocampal Volume in mild cognitive impairment. Neurology 1999;52:1397-403.
32. SQUIRE LR. Memory and Brain. New York: Oxford University Press, 1987.
33. VARGHA-KHADEM F, GADIAN DG, WATKINS KE, CONNELLY A, VAN PAESSCHEN W, MISHKIN M. Differential effects of early hippocampal lesions on episodic and semantic memory. Science 1997;277:376-80.
34. LAAKSO MP, SOININEN H, PARTANEN K et al. MRI of the hippocampus in Alzheimer's disease: Sensitivity, specificity, and analysis of the incorrectly classified subjects. Neurobiol Aging 1997;19:23-31.
35. CABEZA R, NYBERG L. Imaging cognition II. An empirical review of 275 PET and fMRI studies. J Cognit Neurosci 2000;12:1-47.
36. LANGLEY LK, MADDEN DJ. Functional neuroimaging of memory: Implications for cognitive aging. Microscopy Res Technique 2000;51:75-84.
37. MORRIS JC, PRICE JL. Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J Mol Neurosci 2001;17:101-18.
38. MORRIS JC, STORANDT M, MCKEEL DW Jr et al. Cerebral amyloid deposition and diffuse plaques in 'normal' aging: Evidence for presymptomatic and very mild Alzheimer's disease. Neurology 1996;46:707-19.
39. SALAT DH, KAYE JA, JANOWSKY JS. Selective preservation and degeneration within the prefrontal cortex in aging and Alzheimer disease. Arch Neurol 2001;58:1403-8.
40. WHEELER MA, STUSS DT, TULVING E. Frontal lobe damage produces episodic memory impairment. JINS 1995;1:525-36.
41. BRAVER TS, BARCH DM, KEYS BA et al. Context processing in older adults: Evidence for a theory relating cognitive control to neurobiology in healthy aging. J Exp Psychol Gen 2001;130:746-63.
42. LI S-C, LINDENBERGER U, SIKSTROM S. Aging cognition: From neuromodulation to representation. TICS 2001;5:479-86.